QTRX
Price
$17.35
Change
-$0.53 (-2.96%)
Updated
May 16, 6:59 PM EST
82 days until earnings call
VCYT
Price
$23.37
Change
-$0.18 (-0.76%)
Updated
May 16, 6:59 PM EST
74 days until earnings call
Ad is loading...

QTRX vs VCYT

Header iconQTRX vs VCYT Comparison
Open Charts QTRX vs VCYTBanner chart's image
Quanterix
Price$17.35
Change-$0.53 (-2.96%)
Volume$140.24K
CapitalizationN/A
Veracyte
Price$23.37
Change-$0.18 (-0.76%)
Volume$396.29K
CapitalizationN/A
View a ticker or compare two or three
QTRX vs VCYT Comparison Chart

Loading...

QTRXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VCYTDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
QTRX vs. VCYT commentary
May 17, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QTRX is a Hold and VCYT is a StrongBuy.

COMPARISON
Comparison
May 17, 2024
Stock price -- (QTRX: $17.88 vs. VCYT: $23.55)
Brand notoriety: QTRX and VCYT are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: QTRX: 117% vs. VCYT: 101%
Market capitalization -- QTRX: $907.82M vs. VCYT: $1.66B
QTRX [@Medical Specialties] is valued at $907.82M. VCYT’s [@Medical Specialties] market capitalization is $1.66B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.47B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

QTRX’s FA Score shows that 0 FA rating(s) are green whileVCYT’s FA Score has 0 green FA rating(s).

  • QTRX’s FA Score: 0 green, 5 red.
  • VCYT’s FA Score: 0 green, 5 red.
According to our system of comparison, VCYT is a better buy in the long-term than QTRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

QTRX’s TA Score shows that 4 TA indicator(s) are bullish while VCYT’s TA Score has 6 bullish TA indicator(s).

  • QTRX’s TA Score: 4 bullish, 5 bearish.
  • VCYT’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, VCYT is a better buy in the short-term than QTRX.

Price Growth

QTRX (@Medical Specialties) experienced а +8.30% price change this week, while VCYT (@Medical Specialties) price change was +17.05% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +2.02%. For the same industry, the average monthly price growth was +4.43%, and the average quarterly price growth was +17.15%.

Reported Earning Dates

QTRX is expected to report earnings on Aug 06, 2024.

VCYT is expected to report earnings on Jul 30, 2024.

Industries' Descriptions

@Medical Specialties (+2.02% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
A.I.dvisor published
a Summary for QTRX with price predictions.
OPEN
A.I.dvisor published
a Summary for VCYT with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
VCYT($1.66B) has a higher market cap than QTRX($908M). VCYT YTD gains are higher at: -14.395 vs. QTRX (-34.601). QTRX has higher annual earnings (EBITDA): -39.79M vs. VCYT (-49.41M). QTRX has more cash in the bank: 321M vs. VCYT (216M). VCYT has less debt than QTRX: VCYT (12.6M) vs QTRX (41.5M). VCYT has higher revenues than QTRX: VCYT (361M) vs QTRX (121M).
QTRXVCYTQTRX / VCYT
Capitalization908M1.66B55%
EBITDA-39.79M-49.41M81%
Gain YTD-34.601-14.395240%
P/E RatioN/AN/A-
Revenue121M361M34%
Total Cash321M216M149%
Total Debt41.5M12.6M329%
FUNDAMENTALS RATINGS
QTRX vs VCYT: Fundamental Ratings
QTRX
VCYT
OUTLOOK RATING
1..100
1745
VALUATION
overvalued / fair valued / undervalued
1..100
36
Fair valued
35
Fair valued
PROFIT vs RISK RATING
1..100
10098
SMR RATING
1..100
9392
PRICE GROWTH RATING
1..100
6350
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VCYT's Valuation (35) in the Biotechnology industry is in the same range as QTRX (36) in the Pharmaceuticals Major industry. This means that VCYT’s stock grew similarly to QTRX’s over the last 12 months.

VCYT's Profit vs Risk Rating (98) in the Biotechnology industry is in the same range as QTRX (100) in the Pharmaceuticals Major industry. This means that VCYT’s stock grew similarly to QTRX’s over the last 12 months.

VCYT's SMR Rating (92) in the Biotechnology industry is in the same range as QTRX (93) in the Pharmaceuticals Major industry. This means that VCYT’s stock grew similarly to QTRX’s over the last 12 months.

VCYT's Price Growth Rating (50) in the Biotechnology industry is in the same range as QTRX (63) in the Pharmaceuticals Major industry. This means that VCYT’s stock grew similarly to QTRX’s over the last 12 months.

VCYT's P/E Growth Rating (100) in the Biotechnology industry is in the same range as QTRX (100) in the Pharmaceuticals Major industry. This means that VCYT’s stock grew similarly to QTRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
QTRXVCYT
RSI
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 1 day ago
89%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
83%
Momentum
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
80%
MACD
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
78%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 14 days ago
81%
Bullish Trend 2 days ago
74%
Declines
ODDS (%)
Bearish Trend 21 days ago
82%
Bearish Trend 21 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
81%
Aroon
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
86%
View a ticker or compare two or three
Ad is loading...
QTRXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VCYTDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RGLDX23.040.23
+1.01%
American Funds Global Insight R-3
JORSX16.340.14
+0.86%
JHancock Small Cap Core R6
VLEQX11.450.08
+0.70%
Villere Equity
GEIZX14.40N/A
N/A
GuideStone Funds Growth Equity Index Inv
CIMDX15.26-0.02
-0.13%
Clarkston Founders Institutional

QTRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, QTRX has been loosely correlated with VCYT. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if QTRX jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QTRX
1D Price
Change %
QTRX100%
+6.30%
VCYT - QTRX
47%
Loosely correlated
+2.30%
MASS - QTRX
42%
Loosely correlated
+1.26%
KIDS - QTRX
41%
Loosely correlated
+0.16%
CDNA - QTRX
41%
Loosely correlated
-3.02%
CERS - QTRX
40%
Loosely correlated
-0.49%
More

VCYT and

Correlation & Price change

A.I.dvisor indicates that over the last year, VCYT has been closely correlated with NTLA. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if VCYT jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VCYT
1D Price
Change %
VCYT100%
+2.30%
NTLA - VCYT
69%
Closely correlated
+1.90%
VCEL - VCYT
60%
Loosely correlated
+1.81%
TWST - VCYT
58%
Loosely correlated
+0.48%
AXON - VCYT
58%
Loosely correlated
-0.85%
GH - VCYT
58%
Loosely correlated
+4.12%
More